Tutin

Suppliers

Names

[ CAS No. ]:
2571-22-4

[ Name ]:
Tutin

[Synonym ]:
(1S,2R,3S,5R,6R,7R,8S,9R,12R)-2,8-Dihydroxy-12-isopropenyl-7-methyl-11H-spiro[4,10-dioxatetracyclo[7.2.1.0.0]dodecane-6,2'-oxiran]-11-one
Toot poison
[1aS-(1aa,1bb,2b,5b,6a,6ab,7b,7aa,8S*)]-Hexahydro-1b,6-dihydroxy-6a-methyl-8-(1-methylethenyl)spiro(2,5-methano-7H-oxireno[3,4]cyclopent[1,2-d]oxepin-7,2'-oxiran)-3(2H)-one
(1aS,1bR,2S,5R,6S,6aR,7R,7aR,8R)-1b,6-dihydroxy-6a-methyl-8-(prop-1-en-2-yl)hexahydrospiro[2,5-methanooxireno[3,4]cyclopenta[1,2-d]oxepine-7,2'-oxiran]-3(2H)-one
Tutu
(1S,2R,3S,5R,6R,7R,8S,9R,12R)-2,8-Dihydroxy-7-methyl-12-(prop-1-en-2-yl)-11H-spiro[4,10-dioxatetracyclo[7.2.1.0.0]dodecane-6,2'-oxiran]-11-one

Chemical & Physical Properties

[ Density]:
1.5±0.1 g/cm3

[ Boiling Point ]:
550.9±50.0 °C at 760 mmHg

[ Melting Point ]:
209-212°; mp 204-205° (Wakamatsu)

[ Molecular Formula ]:
C15H18O6

[ Molecular Weight ]:
294.300

[ Flash Point ]:
212.6±23.6 °C

[ Exact Mass ]:
294.110352

[ PSA ]:
91.82000

[ LogP ]:
1.38

[ Vapour Pressure ]:
0.0±3.4 mmHg at 25°C

[ Index of Refraction ]:
1.637

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
WH1314800
CHEMICAL NAME :
Spiro(2,5-methano-7H-oxireno(3,4)cyclopent(1,2-d)oxep in-7,2'-oxiran)-3(2ah )-one, 1a-beta, 1b,5a,6,6a,7a-beta-hexahydro-1b-alpha,6-beta-dihydrox y-8a-isopropenyl-6a-a lpha-methyl-
CAS REGISTRY NUMBER :
2571-22-4
LAST UPDATED :
199007
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C15-H18-O6
MOLECULAR WEIGHT :
294.33
WISWESSER LINE NOTATION :
T D3 C565 A EO GX KOVTJ AY1&U1 CQ H1 IQ G-& BT3OX CHJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 11,729,1968
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3613 ug/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. Volume(issue)/page/year: 29,2,1940
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
1521 ug/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. Volume(issue)/page/year: 29,2,1940
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
1244 ug/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. Volume(issue)/page/year: 29,2,1940
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
1666 ug/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - coma Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 2,73,1910
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
2 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - coma Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 2,73,1910

Related Compounds

  • 1-(4-methyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)propan-2-ol
  • 3-(Aminomethyl)-3-(methanesulfonylmethyl)cyclobutan-1-ol
  • 4-(4-methyl-1,3-oxazol-2-yl)-N-(propan-2-yl)aniline
  • 2-{N-ethyl-2-[1-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclobutyl]acetamido}acetic acid
  • tert-butyl N-[3-amino-2-(1-methyl-1H-pyrazol-5-yl)propyl]carbamate
  • 3-{6,6-Dimethylbicyclo[3.1.1]heptan-2-yl}azetidine
  • O-[(2-tert-butyl-2H-1,2,3,4-tetrazol-5-yl)methyl]hydroxylamine
  • [1-({6-Methylimidazo[2,1-b][1,3]thiazol-5-yl}methyl)cyclopropyl]methanamine
  • 2-(2-Methylpyridin-4-yl)ethane-1-sulfonyl chloride
  • 4-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methylbutanoyl]morpholine-3-carboxylic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.